iiT Research & Development GmbH
CEO: Univ. Prof. Dr. Richard Greil
The iiT invites applications for a researcher in tumor-immune systems biology. We seek researchers to develop tools to investigate and to model the interaction of cancer cells, in particular leukemia and lymphoma cells, with the tumor-immune microenvironment and how this interaction changes during disease progression and therapies.
Experience and Expertise
The work comprises analyses of human and murine tissues as well as cell line models. Candidates should have a strong background in biostatistics, mathematics or bioinformatics and skilled in analysing complex, multiparametric data from repositories. They should have experience in performing and analysing immune-profiling, NGS and similar technologies and should have good project-, self-, and team management qualities. Candidates must have a PhD, MD, or an equivalent graduate degree. Non-traditional applicants, such as those from industry, are particularly encouraged to apply.
Who we are
The iiT (individualized immune Therapy) Research and Development company (Ltd.) is a novel spinoff of the Salzburg Cancer Research Institute (SCRI) and is therefore tightly embedded in the local research environment (limcr.at and cccit.at) and the pharmaceutical industry. The position will offer an exciting job in a supportive environment in a seminal field of research. The gross annual salary will be 84.000 € (40h/week) but can be negotiated depending on qualifications and relevant professional experience.
The deadline for applications is July 15, 2024.
If you meet the requirements profile and are interested in working in a committed team, please send your application with reference to the advertised position to:
iiT Research & Development GmbH
z.H. Hr. Univ. Prof. Dr. Richard Greil
Wolfsgartenweg 31
5020 Salzburg
or by email: r.greil@me.com
s.traninger@iit-research.at
